These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4298410)

  • 21. The susceptibility of enteropathogenic and non-enteropathogenic porcine Escherichia coli strains to polymyxins and other antibiotics.
    Larsen JL; Søgaard H
    Nord Vet Med; 1981; 33(9-11):393-402. PubMed ID: 6276857
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of polymyxin B on ion permeability of bacterial membranes].
    Kapitanova NG; Korepanova EA; Gariaev AA; Frolov VN; Antonov VF
    Biofizika; 1981; 26(6):1100-2. PubMed ID: 6274432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B.
    Rosenthal KS; Storm DR
    J Antibiot (Tokyo); 1977 Dec; 30(12):1087-92. PubMed ID: 202585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism of the antimicrobial agents miconazole, bacitracin and polymyxin B.
    Cornelissen F; Van den Bossche H
    Chemotherapy; 1983; 29(6):419-27. PubMed ID: 6317296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cell wall of Escherichia coli: early effects of penicillin treatment and deprivation of diaminopimelic acid.
    Bayer ME
    J Gen Microbiol; 1967 Feb; 46(2):237-46. PubMed ID: 5339792
    [No Abstract]   [Full Text] [Related]  

  • 26. The outer membrane permeability-increasing action of deacylpolymyxins.
    Viljanen P; Matsunaga H; Kimura Y; Vaara M
    J Antibiot (Tokyo); 1991 May; 44(5):517-23. PubMed ID: 1648055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mathematical study of the sensitivity curves of Escherichia coli exposed to polymyxins].
    Peyret M; Carret G; Carre C; Fardel G; Flandrois JP
    Pathol Biol (Paris); 1990 May; 38(5):441-5. PubMed ID: 2164182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the interaction between endotoxin and polymyxin B.
    Rifkind D
    J Infect Dis; 1967 Dec; 117(5):433-8. PubMed ID: 4294922
    [No Abstract]   [Full Text] [Related]  

  • 29. Ultrastructural surface alterations of serratia marcescens after exposure to polymyxin B and/or fresh human serum.
    Traub WH; Acker G; Kleber I
    Chemotherapy; 1976; 22(2):104-13. PubMed ID: 176013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mode of action of polymyxin B: physiological studies with Bacillus subtilis-resistant mutant.
    Galizzi A; Cacco G; Siccardi AG; Mazza G
    Antimicrob Agents Chemother; 1975 Sep; 8(3):366-9. PubMed ID: 170857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding to and antibacterial effect of ampicillin, neomycin and polymyxin B on human faeces.
    Hazenberg MP; Pennock-Schröder AM; Van den Boom M; Van de Merwe JP
    J Hyg (Lond); 1984 Aug; 93(1):27-34. PubMed ID: 6086749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymyxin B binding sites in Escherichia coli as revealed by polymyxin B-gold labeling.
    Morioka H; Tachibana M; Machino M; Suganuma A
    J Histochem Cytochem; 1987 Feb; 35(2):229-31. PubMed ID: 3025293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on polymyxin B].
    Ueda Y; Nakamura N; Matsumoto F; Saito A; Noda K
    Jpn J Antibiot; 1968 Oct; 21(5):247-9. PubMed ID: 4303514
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibiotic-induced alterations in the surface morphology of bacterial cells: a scanning-beam electron miscroscopy study.
    Klainer AS; Perkins RL
    J Infect Dis; 1970 Oct; 122(4):323-8. PubMed ID: 4994168
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell composition and drug resistance in Escherichia coli.
    Hugo WB; Ellis JO
    Microbios; 1978; 21(85-86):135-52. PubMed ID: 221791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of gram-negative bacteria to the synergistic bactericidal action of serum and polymyxin B nonapeptide.
    Viljanen P; Käyhty H; Vaara M; Vaara T
    Can J Microbiol; 1986 Jan; 32(1):66-9. PubMed ID: 3008971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broad-spectrum derivatives of polymyxin B and colistin.
    Witzke NM; Heding H
    J Antibiot (Tokyo); 1976 Dec; 29(12):1349-50. PubMed ID: 188797
    [No Abstract]   [Full Text] [Related]  

  • 38. Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli.
    Fierer J; Finley F
    J Infect Dis; 1979 Oct; 140(4):581-9. PubMed ID: 229175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of tetracycline, polymyxin B, and rifampin on phagocytosis.
    Hoeprich PD; Martin CH
    Clin Pharmacol Ther; 1970; 11(3):418-22. PubMed ID: 4392562
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of polymyxin B nonapeptide (PMBN) on transformation.
    Viljanen P
    Biochem Biophys Res Commun; 1987 Mar; 143(3):923-7. PubMed ID: 3032189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.